Vitamin K2 (menatetrenone) Effectively Prevents Fractures And Sustains Lumbar Bone Mineral Density In Osteoporosis
Notes for this study:
|Number of Subjects
45mg of MK-4 daily for 2 years in persons with osteoporosis is able to reduce both the fracture rate as well as prevent the losses of bone mineral density in the spinal region relative to placebo. There was a trend to increase bone mineral density after the 2 year period, but this failed to reach statistical significance and was small in magnitude.